Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Bioventus Inc. - news published 278 - readings 6.991

BACK

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSIO ...

25.03.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

21.03.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.03.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

18.03.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Bioventus Inc.

Q4'24 Earnings Call Slides

Fourth Quarter 2024 Financial Results March 11, 2025 Agenda and Speakers Rob Claypoole Mark Singleton President and Senior Vice-President Chief Executive Officer and Chief Financial Officer Update on Business Q4 2024 Results Outline 2025 Priorities 2025 Financial Guidance Forward Looking Statements and Use of Estimates Forward-Looking Statements This presentation contains forw ...

11.03.2025

Bioventus Inc.

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

PDF Version Accelerated fourth quarter sales growth to 13.5% Fourth quarter gross margin expanded 310 bps and adjusted gross margin* expanded 230 bps Fourth quarter cash from operations of $19.3 million increased 86.3% Provides full-year 2025 financial guidance reflecting continued above market revenue growth and continued operating margin expansion DURHAM, N.C., March 11, 202 ...

11.03.2025

Bioventus Inc.

Initial Registration Statement for Employee Benefit Plan (Form S-8)

As filed with the Securities and Exchange Commission on March 11, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bioventus Inc. (Exact name of registrant as specified in its charter) Delaware 81-0980861 (State or other jurisdiction of incorporation or organizati ...

11.03.2025

Bioventus Inc.

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)

Management's Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with Part I, Item 1A. Risk Factors and our consolidated financial statements and the related notes to those statements included elsewhere in this Annual Report on Form 10- ...

11.03.2025

Bioventus Inc.

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results (Form 8-K)

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results •Accelerated fourth quarter sales growth to 13.5% •Fourth quarter gross margin expanded 310 bps and adjusted gross margin* expanded 230 bps •Fourth quarter cash from operations of $19.3 million increased 86.3% •Provides full-year 2025 financial guidance reflecting continued above market revenue gro ...

11.03.2025

Bioventus Inc.

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Bioventus Inc. published this content on February 28, 2025 , and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on February 28, 2025 at 13:20:20.892 .

28.02.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

21.02.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

21.02.2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

21.02.2025

Bioventus Inc. - news published 278 - readings 6.991

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Q4'24 Earnings Call Slides

Bioventus Inc.

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

Bioventus Inc.

Initial Registration Statement for Employee Benefit Plan (Form S-8)

Bioventus Inc.

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)

Bioventus Inc.

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results (Form 8-K)

Bioventus Inc.

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Bioventus Inc.

Statement of Changes in Beneficial Ownership (Form 4)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member